These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35933704)

  • 1. Manufacturing with pluripotent stem cells (PSConf 2021): Key issues for future research and development.
    Stacey GN; Cao J; Hu B; Zhou Q
    Cell Prolif; 2022 Aug; 55(8):e13301. PubMed ID: 35933704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cell culture conditions and stability: a joint workshop of the PluriMes Consortium and Pluripotent Stem Cell Platform.
    Stacey GN; Andrews PW; Barbaric I; Boiers C; Chandra A; Cossu G; Csontos L; Frith TJ; Halliwell JA; Hewitt Z; McCall M; Moore HD; Parmar M; Panico MB; Pisupati V; Shichkin VP; Stacey AR; Tedesco FS; Thompson O; Wagey R
    Regen Med; 2019 Mar; 14(3):243-255. PubMed ID: 30938271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technological progress and challenges towards cGMP manufacturing of human pluripotent stem cells based therapeutic products for allogeneic and autologous cell therapies.
    Abbasalizadeh S; Baharvand H
    Biotechnol Adv; 2013 Dec; 31(8):1600-23. PubMed ID: 23962714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety of human pluripotent stem cells in clinical treatment.
    Simonson OE; Domogatskaya A; Volchkov P; Rodin S
    Ann Med; 2015; 47(5):370-80. PubMed ID: 26140342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biobanking of human pluripotent stem cells in China.
    Stacey GN; Hao J
    Cell Prolif; 2022 Jul; 55(7):e13180. PubMed ID: 35652319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrogel-Based Bioprocess for Scalable Manufacturing of Human Pluripotent Stem Cell-Derived Neural Stem Cells.
    Lin H; Du Q; Li Q; Wang O; Wang Z; Liu K; Elowsky C; Zhang C; Lei Y
    ACS Appl Mater Interfaces; 2018 Sep; 10(35):29238-29250. PubMed ID: 30091584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulating cell state to enhance suspension expansion of human pluripotent stem cells.
    Lipsitz YY; Woodford C; Yin T; Hanna JH; Zandstra PW
    Proc Natl Acad Sci U S A; 2018 Jun; 115(25):6369-6374. PubMed ID: 29866848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
    Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
    Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microcarrier-based platforms for in vitro expansion and differentiation of human pluripotent stem cells in bioreactor culture systems.
    Badenes SM; Fernandes TG; Rodrigues CAV; Diogo MM; Cabral JMS
    J Biotechnol; 2016 Sep; 234():71-82. PubMed ID: 27480342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical translation of pluripotent stem cell-based therapies: successes and challenges.
    Christiansen JR; Kirkeby A
    Development; 2024 Apr; 151(7):. PubMed ID: 38564308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the selective growth advantage of genetically variant human pluripotent stem cells to identify opportunities for manufacturing process control.
    Beltran-Rendon C; Price CJ; Glen K; Stacey A; Barbaric I; Thomas RJ
    Cytotherapy; 2024 Apr; 26(4):383-392. PubMed ID: 38349312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High density bioprocessing of human pluripotent stem cells by metabolic control and in silico modeling.
    Manstein F; Ullmann K; Kropp C; Halloin C; Triebert W; Franke A; Farr CM; Sahabian A; Haase A; Breitkreuz Y; Peitz M; Brüstle O; Kalies S; Martin U; Olmer R; Zweigerdt R
    Stem Cells Transl Med; 2021 Jul; 10(7):1063-1080. PubMed ID: 33660952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human pluripotent stem cell-derived products: advances towards robust, scalable and cost-effective manufacturing strategies.
    Jenkins MJ; Farid SS
    Biotechnol J; 2015 Jan; 10(1):83-95. PubMed ID: 25524780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pluripotent Stem Cells in Clinical Setting-New Developments and Overview of Current Status.
    Ilic D; Ogilvie C
    Stem Cells; 2022 Sep; 40(9):791-801. PubMed ID: 35671338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical-Grade Human Pluripotent Stem Cells for Cell Therapy: Characterization Strategy.
    Rehakova D; Souralova T; Koutna I
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Science-based assessment of source materials for cell-based medicines: report of a stakeholders workshop.
    Stacey G; Andrews P; Asante C; Barbaric I; Barry J; Bisset L; Braybrook J; Buckle R; Chandra A; Coffey P; Crouch S; Driver P; Evans A; Gardner J; Ginty P; Goldring C; Hay DC; Healy L; Hows A; Hutchinson C; Jesson H; Kalber T; Kimber S; Leathers R; Moyle S; Murray T; Neale M; Pan D; Park BK; Rebolledo RE; Rees I; Rivolta MN; Ritchie A; Roos EJ; Saeb-Parsy K; Schröder B; Sebastian S; Thomas A; Thomas RJ; Turner M; Vallier L; Vitillo L; Webster A; Williams D
    Regen Med; 2018 Dec; 13(8):935-944. PubMed ID: 30488776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of human pluripotent stem cells and pluripotent stem cell-derived cellular models for assessing drug toxicity.
    Apáti Á; Varga N; Berecz T; Erdei Z; Homolya L; Sarkadi B
    Expert Opin Drug Metab Toxicol; 2019 Jan; 15(1):61-75. PubMed ID: 30526128
    [No Abstract]   [Full Text] [Related]  

  • 18. Production of human pluripotent stem cell therapeutics under defined xeno-free conditions: progress and challenges.
    Fan Y; Wu J; Ashok P; Hsiung M; Tzanakakis ES
    Stem Cell Rev Rep; 2015 Feb; 11(1):96-109. PubMed ID: 25077810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The suspension culture of undifferentiated human pluripotent stem cells using spinner flasks.
    Chen VC; Couture LA
    Methods Mol Biol; 2015; 1283():13-21. PubMed ID: 25537838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Feeding Strategies on the Scalable Expansion of Human Pluripotent Stem Cells in Single-Use Stirred Tank Bioreactors.
    Kropp C; Kempf H; Halloin C; Robles-Diaz D; Franke A; Scheper T; Kinast K; Knorpp T; Joos TO; Haverich A; Martin U; Zweigerdt R; Olmer R
    Stem Cells Transl Med; 2016 Oct; 5(10):1289-1301. PubMed ID: 27369897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.